An official website of the United States government Here’s how you know

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

In this section: Vaccines, Blood & Biologics

AREPANRIX

STN: 125419
Proper Name: Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted
Tradename: AREPANRIX
Manufacturer: ID Biomedical Corporation of Quebec
Indication:

AREPANRIX is a vaccine indicated for active immunization for the prevention of disease caused by the influenza A virus H5N1 subtype contained in the vaccine.
AREPANRIX is approved for use in individuals 6 months and older at increased risk of exposure to the influenza A virus H5N1 subtype contained in the vaccine.

Product Information

Package Insert - AREPANRIX

Supporting Documents

October 18, 2024 Approval Letter - AREPANRIX

Top